NCT02707328 · Interventional trial
Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002)
Overall registry status Terminated
Phase 1
Conditions Adenocarcinoma of the Pancreas, Pancreas Adenocarcinoma, Pancreas Cancer, Pancreatic Adenocarcinoma, Pancreatic Cancer
Delaware Valley sites
- MD Anderson Cancer Center at Cooper · Camden, NJ · Camden County
First posted
Registry updated
Added to the directory